You are here

Article info

Article menu
Download PDFPDF
Original research
Proposal to distinguish HER2-low from HER2-normal breast cancer by in situ hybridisation

Authors

  • Yen-Ying Chen Department of Pathology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Ching-Fen Yang School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Chih-Yi Hsu School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan College of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chih-Yi Hsu, Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; cyhsu{at}vghtpe.gov.tw
View Full Text

Citation

Chen Y, Yang C, Hsu C
Proposal to distinguish HER2-low from HER2-normal breast cancer by in situ hybridisation
Journal of Clinical Pathology 2023;76:753-756.

Publication history

  • Received June 8, 2022
  • Accepted August 21, 2022
  • First published September 1, 2022.
Online issue publication 
January 22, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.